Home
»
Press Room
»
Local Anesthesia Drugs Market To Reach $5.13Bn By 2030

Local Anesthesia Drugs Market To Reach $5.13 Billion By 2030

May 2025 | Report Format: Electronic (PDF)

Local Anesthesia Drugs Market Growth & Trends

The global local anesthesia drugs market size is anticipated to reach USD 5.13 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 3.70% from 2025 to 2030. The rising number of surgical procedures across the globe, including cosmetic surgeries, dental procedures, and plastic surgeries, is driving the growth of local anesthetics.

There has been a considerable increase in the number of surgical procedures requiring post-operative pain relief and this trend is expected to continue throughout the forecast period. Roughly, 65.0% of total surgical procedures require post-operative pain management. This is likely to boost the demand for local anesthesia drugs.

The introduction of new and effective drugs such as levobupivacaine, articaine, and ropivacaine is also driving the growth of the local anesthesia drugs market across the globe. Rising healthcare expenditure in developing countries is expected to result in an increase in the number of surgeries performed in countries such as India, China, and Brazil. This is likely to contribute to market growth in the region.

key Request a free sample copy or view report summary: Local Anesthesia Drugs Market Report

Local Anesthesia Drugs Market Report Highlights

By application, the market is bifurcated into injectable and surface anesthetic. The injectable segment is expected to dominate the local anesthesia drugs market during the forecast period owing to extensive usage in different surgical procedures. Advancements in drug delivery systems are expected to drive the market for surface anesthetics over the forecast period.
North America held the largest share in the market for local anesthesia drugs owing to a significant number of surgical procedures performed in the region.
Asia Pacific local anesthesia drugs industry is anticipated to witness the fastest CAGR over the forecast period due to rapid urbanization and improvements in healthcare infrastructure.
By Drug segment, Lidocaine dominated the market with a 28.88% share in 2024, driven by its extensive use in injectable and topical anesthetic formulations.